Create Medic (5187) Q1 2026 earnings summary

Executive summary

• Net sales for Q1 2026 rose 4.5% year-over-year to ¥3,364 million, with operating profit down 36.6% to ¥140 million and ordinary profit down 21.3% to ¥169 million.

• Profit attributable to owners of parent decreased 26.7% year-over-year to ¥153 million.

• Comprehensive income for Q1 2026 was ¥408 million, a significant turnaround from a loss of ¥193 million in Q1 2025.

Financial highlights

• Basic earnings per share for Q1 2026 was ¥18.40, down from ¥24.38 in Q1 2025.

• Total assets as of March 31, 2026 were ¥19,918 million, with net assets at ¥16,260 million.

• Capital adequacy ratio stood at 81.6% as of March 31, 2026.

Outlook and guidance

• Full-year 2026 net sales forecasted at ¥13,960 million, up 2.5% year-over-year.

• Operating profit for 2026 expected to rise 55% to ¥1,060 million; ordinary profit to increase 8.3% to ¥1,070 million.

• Profit attributable to owners of parent projected at ¥750 million, up 5.1% year-over-year.

• Basic earnings per share for 2026 forecasted at ¥89.44.